Comment on: CD163 as a valuable diagnostic and prognostic biomarker of sepsis-associated hemophagocytic lymphohistiocytosis in critically ill children. A call for HLA-DR in HLH.

Monneret, Guillaume; Gossez, Morgane; Rimmelé, Thomas; Venet, Fabienne

Monneret, Guillaume; Gossez, Morgane; Rimmelé, Thomas; Venet, Fabienne.

Afiliação

Monneret G; Cellular Immunology Laboratory, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.
Gossez M; EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Hôpital Edouard Herriot, Lyon, France.
Rimmelé T; Cellular Immunology Laboratory, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France.
Venet F; EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Hôpital Edouard Herriot, Lyon, France.

Pediatr Blood Cancer ; 67(1): e27979, 2020 01.

Article em En | MEDLINE | ID: mdl-31599478

Assuntos

Linfo-Histiocitose Hemofagocítica; Sepse; Criança; Estado Terminal; Antígenos HLA-DR; Humanos; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse / Linfo-Histiocitose Hemofagocítica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google